English | Français | Deutsch | Italiano | Español | Português | Русский язык
Connect with us:
Virtual Data Room
RSS

Knowledge Center

Find out about critical issues affecting business today and the solutions that can help you drive your deals to a successful close. Check out our extensive library of White Papers and Survey Reports and gain an insight into the current M&A trends, inherent challenges in doing deals and much, much more.

Please select the reports you would like to receive below and gain access to our extensive library of offers, all under one link. Access any of our reports at the click of the mouse, free of charge.



PitchBook 2014 Annual European PE Breakdown Report



Merrill DataSite in partnership with PitchBook presents The PitchBook 2014 Annual European PE Breakdown Report, which provides a review of European private capital dealflow, exits and fundraising activity. This report should provide insight and inform your decision-making process in the coming quarters.



PitchBook 4Q 2014 Canada PE Breakdown Report


Merrill DataSite in partnership with PitchBook presents the Canada PE Breakdown 4Q 2014 report which provides a review of Canadian private capital dealflow, exits and fundraising activity from 2009 through to the third quarter of 2014. The report provides useful insight to help plan for investment endeavors for the remainder of the year.



PitchBook 4Q 2014 Private Equity Breakdown Report

PitchBook 4Q 2014 Private Equity Breakdown Report

Merrill DataSite in partnership with PitchBook presents the 4Q 2014 Private Equity Breakdown report which provides a review of all U.S private equity investment, exits and fundraising activity in the third quarter of 2014.



PitchBook 3Q 2014 Private Equity Breakdown Report

PitchBook 3Q 2014 Private Equity Breakdown Report

Merrill DataSite in partnership with PitchBook presents the 3Q 2014 Private Equity Breakdown report which provides a review of all U.S private equity investment, exits and fundraising activity in the second quarter of 2014.



PitchBook 2Q 2014 U.S. Privarte Equity Breakdown Report

PitchBook 2Q 2014 Private Equity Breakdown Report  

Merrill DataSite in partnership with PitchBook presents the 2Q 2014 U.S. PE Breakdown report which provides a review of all U.S private equity investment, exits and fundraising activity in the first quarter of 2014.



Deal Drivers 2014 Half Year Report for the Americas

Deal Drivers 2014 Half Year Report for the Americas

Merrill Datasite in association with mergermarket presents Deal Drivers 2014 Half Year Report for the Americas. This report provides a comprehensive review of M&A activity in both North and South America, with targeted analysis of regional and sector-specific trends.



Deal Drivers 2013 Full Year Report for the Americas

Deal Drivers 2013 Full Year Report for the Americas

Merrill Datasite in association with mergermarket presents Deal Drivers 2013 Full Year Report for the Americas. This report provides a comprehensive review of M&A activity in both North and South America, with targeted analysis of regional and sector-specific trends.



The Best Practices of the Best M&A Dealmakers – Strategy and Synergy: Vital Elements of the Deal

The Best Practices of the Best M&A Dealmakers – Strategy and Synergy: Vital Elements of the Deal

In this, the first chapter from the third series of the Best Practices of the Best Dealmakers Guide “Strategy and Synergy: Vital Elements of the Deal” we discuss the best practices for formulating an M&A strategy in order to help ensure the appropriateness of an acquisition or a sale in terms of the synergies to be realized as the transaction’s end product.



The Best Practices of the Best M&A Dealmakers – Halcyon Days Are Here Again: The Return of Antitrust to M&A

The Best Practices of the Best M&A Dealmakers – Halcyon Days Are Here Again: The Return of Antitrust to M&A

Drawing on the experience and expertise of the ‘best in class’ dealmakers, The M&A Advisor, together with Merrill Datasite, is publishing the quintessential dealmakers guide series – The Best Practices of The Best Dealmakers. In this Special Report, “Halcyon Days Are Here Again: The Return of Antitrust to M&A” we explore the onset of a new era in antitrust scrutiny of M&A deals large and small.



The Best Practices of the Best M&A Dealmakers - Refocusing Traditional Due Diligence: Value Creation in Today’s Ultra-Competitive Deal Environment

The Best Practices of the Best M&A Dealmakers – Refocusing Traditional Due Diligence: Value Creation in Today’s Ultra-Competitive Deal Environment

This installment of The Best Practices of the Best M&A Dealmakers: “Refocusing Traditional Due Diligence: Value Creation in Today’s Ultra-Competitive Deal Environment” focuses on the best practices for executing the due diligence process in M&A transactions, with a growing emphasis on strategic value creation.



The Best Practices of the Best M&A Dealmakers - The Science and Art of Deal Execution: Where Metrics and Innovation Converge

The Best Practices of the Best M&A Dealmakers – The Science and Art of Deal Execution: Where Metrics and Innovation Converge

This installment of The Best Practices of the Best M&A Dealmakers: “The Science and Art of Deal Execution: Where Metrics and Innovation Converge” discusses the quantitative foundations of dealmaking, the metrics and measures that underpin each phase of the deal process.



Best Practices of the Best Dealmakers - Creating and Executing a Winning M&A Strategy

The Best Practices of the Best M&A Dealmakers – Creating and Executing a Winning M&A Strategy

This installment of The Best Practices of The Best Dealmakers “Creating and Executing a Winning M&A Strategy” addresses how the most successful M&A dealmakers are refining their approach to win in today’s competitive deal environment.



Best Practices of the Best Dealmakers - Driving Successful Cross-Border M&A Transactions

The Best Practices of the Best M&A Dealmakers – Driving Successful Cross-Border M&A Transactions 

This installment of The Best Practices of The Best Dealmakers: “Driving Successful Cross-Border M&A Transactions” discusses best practices for executing an effective cross-border M&A acquisition strategy.



Best Practices of the Best Dealmakers - Opportunity and Risk: Uncovering and Winning the Distressed Deal

The Best Practices of the Best M&A Dealmakers – Opportunity and Risk: Uncovering and Winning the Distressed Deal

This installment of The Best Practices of The Best Dealmakers: “Opportunity and Risk: Uncovering and Winning the Distressed Deal” discusses best practices for buyers and sellers of distressed companies and their assets.



The Best Practices of the Best M&A Dealmakers – Negotiating, Valuing & Structuring Deals cover

The Best Practices of the Best M&A Dealmakers – Negotiating, Valuing & Structuring Deals

"Negotiating, Valuing & Structuring Deals" outlines the best negotiating practices for buyers, sellers and their advisors.

 



The Road to Recovery: Mastering the Art of Distressed Investing

The Best Practices of The Best M&A Dealmakers - The Road to Recovery: Mastering the Art of Distressed Investing

This second part of the third chapter of the The Best Practices of The Best M&A Dealmakers series outlines best practices for buyers of a distressed company or its assets.



The Road to Recovery: Creating Value from Distressed Companies

The Best Practices of The Best M&A Dealmakers - Road to Recovery: Creating Value from Distressed Companies

The third chapter of the The Best Practices of The Best M&A Dealmakers series is presented in two parts, which will outline best practices for both buyers and sellers of a distressed company or its assets. This first part focuses on the complex business of turning around a distressed company from within.



Mitigating Risk and Creating Value: A Focused Approach to Due Diligence

The Best Practices of the Best Dealmakers - Mitigating Risk and Creating Value: A Focused Approach to Due Diligence

This second chapter of the Best Practices of the Best M&A Dealmakers series illustrates the redefinition of due diligence in today’s market and how it can be applied to due diligence planning, methodology, and team organization.



The Best Practices of The Best M&A Dealmakers

The Best Practices of The Best M&A Dealmakers - Dynamics of Culture – The Impact of Cultural Integration on Cross-border M&A

The first chapter in this series, Dynamics of Culture – The Impact of Cultural Integration on Cross-border M&A, addresses the many facets and challenges dealmakers face today and was created precisely for the International M&A dealmakers to gain a better insight into the cultural challenges and how experts in the industry have managed to overcome them.



Seven Critical M&A Transaction Mistakes: How to avoid common M&A pitfalls

Seven Critical M&A Transaction Mistakes: How to avoid common M&A pitfalls

Even the best M&A opportunities can be derailed by a single misstep. That's why it is essential to understand and avoid the most common pitfalls that can disrupt or even kill a deal. This white paper outlines the steps you can take to uncover synergy savings and prevent deal fatigue.



Avoiding the Common Pitfalls in M&A Transactions

Avoiding the Common Pitfalls in M&A Transactions

This ROUNDTABLE report summarizes and enhances a discussion between a panel of M&A professionals on how to orchestrate successful M&A transactions focusing on the common mistakes which result in failed deals.



BioPharma Partnerships Go Virtual cover

BioPharma Partnerships Go Virtual

Top BioPharma companies reveal how organizations are filling up their R&D pipeline with promising ideas, and building critical relationships to keep their businesses vibrant and future-oriented.



Principles to Help Understand the Science and Art of Your IP Valuation cover

Principles to Help Understand the Science and Art of Your IP Valuation

This IP valuation special report is an invaluable tool to help you select the appropriate valuation methods, perform credible due diligence and construct effective valuation models and reports.



Biotech Companies Need to Be Opportunistic cover

Biotech Companies Need to Be Opportunistic

This biotech special report updates you on today’s competitive life sciences funding environment, helping you navigate the challenges successfully.



Today's Key Healthcare Innovation Principles cover

Today's Key Healthcare Innovation Principles

This healthcare must-keep guide provides a critical analysis of innovation opportunity and the considerations one must review within each of the following healthcare sectors: Pharmaceutical, Biotechnological, Medical Device and Information Technology.



Negotiation Between Healthcare Professionals and Venture Capitalists cover

Negotiation Between Healthcare Professionals and Venture Capitalists

This healthcare special report provides you with information on the needed preparation, terms and process guidelines to ensure the best outcomes of a negotiation.



Healthcare Valuation:  How to Prepare and Effectively Defend Your Position

Healthcare Valuation: How to Prepare and Effectively Defend Your Position

This healthcare special report offers a detailed description of the different methods of valuation, based on objective data and subjective elements.



Executing Effective M&A Part 3

Executing Effective M&A, part 3 - Post deal integration

In this paper we examine industry best practices for maximising value and capturing synergies after the deal is done. Thinking innovatively and leveraging best-in-class technology to facilitate communication can enhance prospects for a successful post-merger integration and the creation of lasting value.



Pharma Experimentation & Innovation  An In-Depth Look at Two Strategies Cover

Pharma Experimentation & Innovation: An In-Depth Look at Two Strategies

This pharma special report provides an intimate look at two strategies that are using innovation and experimentation to drive growth.



Academic and Pharma Partnerships:  Tapping the Ivory Tower for the Next Blockbuster

Academic and Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster

This unique Life Sciences Special Report examines the unique opportunities and hurdles faced, when the worlds of pharma and academia come together; from managing expectations, adherence to deadlines, enabling and maximizing collaboration, to assuring secure working environments.



Creating Strategic Advantage in the Negotiation of Life Sciences Deals

Creating Strategic Advantage in the Negotiation of Life Sciences Deals

This Life Sciences Special Report helps you practice your negotiation skills. Become a more effective negotiator by walking through a series of stages that optimize your deal-making capabilities.



Royalty Rate Derivation Methods for Pharmaceuticals & Biotechnology

Royalty Rate Derivation Methods for Pharmaceuticals & Biotechnology

This Special Report on Royalty Rates for Pharmaceuticals & Biotechnology is a tool that can be used to optimize the pricing of biotechnology and pharmaceutical intellectual property by providing specific derivation methods.



Cloud Primer for Life Sciences Execs

Cloud Primer For Life Sciences Execs

This unique Life Sciences Special Report highlights the growth of cloud service IT applications, while providing examples of cost savings and efficiency gains that suggest the cloud is gaining traction in the life sciences industry.



Five Best Practices for Life Sciences Companies

Virtually all bio-pharma companies today see in- and out-licensing of their intellectual property as an essential component of their growth strategy. This white paper explores several factors and safeguards that when addressed early-on will help to streamline and secure the process, minimize risk, maintain harmony inside the company and maximize the value of each licensing deal.

Request

Schedule a Demo

Chat with an Expert

Contact Us
Customer Service and Sales

US +1 888 867 0309
Europe +44 (0) 207 562 3200
New Zealand 0800 311 703
info@datasite.com

Technical Support

U.S. / Canada +1 877 494 6777
International +1 651 632 4370
UK +44 (0) 207 422 6090
Germany +49 (0) 800 000 1308
France +33 (0) 800 913 814
New Zealand 0800 792 085
techsupport@merrillcorp.com

Home  | About | Terms of Use  | Privacy Notice | Services Agreement | Sitemap